A Prospective, Multi-site, Randomized, Sham-Controlled, Double-Blind Trial With One-Way Crossover Designed to Assess the Effectiveness and Safety of the Gimer NeuroBlock SCS Trialing System for the Treatment of Chronic Back Pain and/or Lower Limb Pain

Clinical trial NCT04693650 · COMPLETED

Trial details

NCT number: NCT04693650
Sponsor: GiMer Medical
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Pain Low Back Pain Lower Limb Pain

Start date: 2021-03-01
Primary completion: 2022-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.